PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting

Mansi Saxena, Thomas U. Marron, Julia Kodysh, John P. Finnigan, Sayali Onkar, Anna Kaminska, Kevin Tuballes, Ruiwei Guo, Rachel Lubong Sabado, Marcia Meseck, Timothy J. O’Donnell, Robert P. Sebra, Samir Parekh, Matthew D. Galsky, Ana Blasquez, Gustavo Gimenez, Mesude Bicak, Cansu Cimen Bozkus, Daniela Delbeau-Zagelbaum, Denise Rodriguez, Ana Acuna-Villaorduna, Krzysztof J. Misiukiewicz, Marshall R. Posner, Brett A. Miles, Hanna Y. Irie, Amy Tiersten, Deborah B. Doroshow, Andrea Wolf, John Mandeli, Rachel Brody, Andres M. Salazar, Sacha Gnjatic, Jeff Hammerbacher, Eric Schadt, Philip Friedlander, Alexander Rubinsteyn, Nina Bhardwaj

Open source

DOI: 10.1158/2159-8290.cd-24-0934
Published: 2025-03-17
Container: Cancer Discovery
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2159-8290.cd-24-0934,
  title = {PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting},
  author = {Mansi Saxena and Thomas U. Marron and Julia Kodysh and John P. Finnigan and Sayali Onkar and Anna Kaminska and Kevin Tuballes and Ruiwei Guo and Rachel Lubong Sabado and Marcia Meseck and Timothy J. O’Donnell and Robert P. Sebra and Samir Parekh and Matthew D. Galsky and Ana Blasquez and Gustavo Gimenez and Mesude Bicak and Cansu Cimen Bozkus and Daniela Delbeau-Zagelbaum and Denise Rodriguez and Ana Acuna-Villaorduna and Krzysztof J. Misiukiewicz and Marshall R. Posner and Brett A. Miles and Hanna Y. Irie and Amy Tiersten and Deborah B. Doroshow and Andrea Wolf and John Mandeli and Rachel Brody and Andres M. Salazar and Sacha Gnjatic and Jeff Hammerbacher and Eric Schadt and Philip Friedlander and Alexander Rubinsteyn and Nina Bhardwaj},
  year = {2025},
  journal = {Cancer Discovery},
  doi = {10.1158/2159-8290.cd-24-0934},
  url = {https://doi.org/10.1158/2159-8290.cd-24-0934}
}

RIS

TY  - JOUR
TI  - PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting
AU  - Mansi Saxena
AU  - Thomas U. Marron
AU  - Julia Kodysh
AU  - John P. Finnigan
AU  - Sayali Onkar
AU  - Anna Kaminska
AU  - Kevin Tuballes
AU  - Ruiwei Guo
AU  - Rachel Lubong Sabado
AU  - Marcia Meseck
AU  - Timothy J. O’Donnell
AU  - Robert P. Sebra
AU  - Samir Parekh
AU  - Matthew D. Galsky
AU  - Ana Blasquez
AU  - Gustavo Gimenez
AU  - Mesude Bicak
AU  - Cansu Cimen Bozkus
AU  - Daniela Delbeau-Zagelbaum
AU  - Denise Rodriguez
AU  - Ana Acuna-Villaorduna
AU  - Krzysztof J. Misiukiewicz
AU  - Marshall R. Posner
AU  - Brett A. Miles
AU  - Hanna Y. Irie
AU  - Amy Tiersten
AU  - Deborah B. Doroshow
AU  - Andrea Wolf
AU  - John Mandeli
AU  - Rachel Brody
AU  - Andres M. Salazar
AU  - Sacha Gnjatic
AU  - Jeff Hammerbacher
AU  - Eric Schadt
AU  - Philip Friedlander
AU  - Alexander Rubinsteyn
AU  - Nina Bhardwaj
PY  - 2025
JO  - Cancer Discovery
DO  - 10.1158/2159-8290.cd-24-0934
UR  - https://doi.org/10.1158/2159-8290.cd-24-0934
ER  -

APA

Saxena, M., Marron, T. U., Kodysh, J., Finnigan, J. P., Onkar, S., Kaminska, A., Tuballes, K., Guo, R., Sabado, R. L., Meseck, M., O’Donnell, T. J., Sebra, R. P., Parekh, S., Galsky, M. D., Blasquez, A., Gimenez, G., Bicak, M., Bozkus, C. C., Delbeau-Zagelbaum, D., Rodriguez, D., Acuna-Villaorduna, A., Misiukiewicz, K. J., Posner, M. R., Miles, B. A., Irie, H. Y., Tiersten, A., Doroshow, D. B., Wolf, A., Mandeli, J., Brody, R., Salazar, A. M., Gnjatic, S., Hammerbacher, J., Schadt, E., Friedlander, P., Rubinsteyn, A., & Bhardwaj, N. (2025). PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-24-0934

Source records

crossref · retrieved 2026-09-25T15:11:59.858Z